Morphine increases acetylcholine release in the trigeminal nuclear complex

Sleep

Volumn 31, Issue 12, 2008, Pages 1629-1637

  Zhu, Zhenghong ^a,b   Bowman, Heather R ^a   Baghdoyan, Helen A ^a   Lydic, Ralph ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

GABAergic disinhibition; Opioid receptors; Orofacial sensory processing; Upper airway

Indexed keywords

ACETYLCHOLINE; BETHANECHOL; BICUCULLINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MORPHINE; NALOXONE; NORBINALTORPHIMINE; TETRODOTOXIN;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; TRIGEMINAL NUCLEUS;

EID: 57349102262     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/31.12.1629     Document Type: Article

References (86)

1. Sessle BJ, Greenwood LF. Inputs to trigeminal brain stem neurones from facial, oral, tooth pulp and pharyngolaryngeal tissues: I. Responses to innocuous and noxious stimuli. Brain Res 1976;117:211-26.
2. Soja PJ. Modulation of prethalamic sensory inflow during sleep versus wakefulness. In: Lavigne G, Choinière M, Sessle BJ, Soja PJ, eds. Sleep and Pain. Seattle, WA: International Association for the Study of Pain Press; 2007:45-76.
3. Guilleminault C, Huang YS, Kirisoglu C, Chan A. Is obstructive sleep apnea syndrome a neurological disorder? A continuous positive airway pressure follow-up study. Ann Neurol 2005;58:880-7.
4. Bader G, Lavigne G. Sleep bruxism; an overview of an oromandibular sleep movement disorder. Sleep Med Rev 2000;4:27-43.
5. Lavigne GF, Guitard F, Rompre PH, Montplaisir JY. Variability in sleep bruxism activity over time. J Sleep Res 2001;10:237-44.
6. Mignogna MD, Fedele S, Lo Russo L. The World Cancer Report and the burden of oral cancer. Eur J Cancer Prev 2004;13:139-42.
7. Lydic R, Baghdoyan HA. Neurochemical mechanisms mediating opioid-induced REM sleep disruption. In: Lavigne G, Choinière M, Sessle BJ, Soja PJ, eds. Sleep and Pain. Seattle, WA: International Association for the Study of Pain Press; 2007:99-122.
8. Berde CB, Brennan TJ, Raja SN. Opioids: more to learn, improvements to be made. Anesthesiology 2003;98:1309-12.
9. Corbett AD, Henderson G, McKnight AT, Paterson SJ. 75 years of opioid research: the exciting but vain quest for the Holy Grail. Br J Pharmacol 2006;147:S153-S62.
10. Cairns BE, Fragoso MC, Soja PJ. Activity of rostral trigeminal sensory neurons in the cat during wakefulness and sleep. J Neurophysiol 1995;73:2486-98.
11. Cairns BE, McErlane SA, Fragoso MC, Jia WG, Soja PJ. Spontaneous discharge and peripherally evoked orofacial responses of trigemino-thalamic tract neurons during wakefulness and sleep. J Neurosci 1996b;16:8149-59.
12. Dal Bo G, Lund JP, Verdier D, Kolta A. Inputs to nucleus pontis caudalis from adjacent trigeminal areas. Eur J Neurosci 2005;22:1987-96.
13. Leonard TO, Lydic R. Pontine nitric oxide modulates acetylcholine release, rapid eye movement sleep generation, and respiratory rate. J Neurosci 1997;17:774-85.
14. Lydic R, Baghdoyan HA. Pedunculopontine stimulation alters respiration and increases ACh release in the pontine reticular formation. Am J Physiol 1993;264:R544-R54.
15. Kohlmeier KA, Soja PJ, Kristensen MP. Disparate cholinergic currents in rat principal trigeminal sensory nucleus neurons mediated by M1 and M2 receptors: a possible mechanism for selective gating of afferent sensory neurotransmission. Eur J Neurosci 2006;23:3245-58.
16. Zhu Z, Baghdoyan HA, Lydic R. Morphine increases principal sensory trigeminal nucleus (PSTN) acetylcholine (ACh) release in anesthetized Wistar rat via GABAergic disinhibition. Sleep 2007;30(Abstract Suppl):005.
17. Bowman HR, Zhu Z, Baghdoyan HA, Lydic R. Acetylcholine release in rat trigeminal motor nucleus is increased by microdialysis delivery of morphine. FASEB J 2008;22:LB148.
18. Skulsky E, Osman NI, Baghdoyan HA, Lydic R. Microdialysis delivery of morphine to the hypoglossal nucleus of Wistar rat increases hypoglossal acetylcholine release. Sleep 2007;30:562-9.
19. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates, 4th ed. New York, NY: Academic Press; 1998.
20. Douglas CL, Baghdoyan HA, Lydic R. M2 muscarinic autoreceptors modulate acetylcholine release in prefrontal cortex of C57BL/6J mouse. J Pharmacol Exp Ther 2001;299:960-6.
21. Coleman CG, Lydic R, Baghdoyan HA. Acetylcholine release in the pontine reticular formation of C57BL/6J mouse is modulated by non-M1 muscarinic receptors. Neuroscience 2004;126:831-8.
22. Osman NI, Baghdoyan HA, Lydic R. Morphine inhibits acetylcholine release in rat prefrontal cortex when delivered systemically or by microdialysis to basal forebrain. Anesthesiology 2005;103:779-87.
23. Wamsley JK, Zarbin MA, Kuhar MJ. Distribution of muscarinic cholinergic high and low affinity agonist binding sites: a light microscopic autoradiographic study. Brain Res Bull 1984;12:233-43.
24. Johnson SW, North RA. Opioids excite dopamine neurons by hyperpolarizing local interneurons. J Neurosci 1992;12:483-8.
25. Watson CJ, Venton BJ, Kennedy RT. In vivo measurements of neurotransmitters using microdialysis sampling. Anal Chem 2006;78:1391-9.
26. Westerink BHC, Cremers TIFH: Handbook of Microdialysis: Methods, Applications and Clinical Aspects. San Diego, CA: Academic Press; 2007:1-697.
27. Baghdoyan HA, Fleegal MA, Lydic R. M2 muscarinic autoreceptors regulate acetylcholine release in the pontine reticular formation. J Pharmacol Exp Ther 1998;286:1446-52.
28. Douglas CL, Baghdoyan HA, Lydic R. Postsynaptic muscarinic M1 receptors activate prefrontal cortical EEG of C57BL/6J mouse. J Neurophysiol 2002;88:3003-9.
29. Coleman CG, Baghdoyan HA, Lydic R. Dialysis delivery of an adenosine A2A agonist into the pontine reticular formation of C57BL/6J mouse increases pontine acetylcholine release and sleep. J Neurochem 2006;96:1750-9.
30. Mortazavi S, Thompson J, Baghdoyan HA, Lydic R. Fentanyl and morphine, but not remifentanil, inhibit acetylcholine release in pontine regions modulating arousal. Anesthesiology 1999;90:1070-7.
31. Bernard R, Lydic R, Baghdoyan HA. Hypocretin (orexin) receptor subtypes differentially enhance acetylcholine release and activate G protein subtypes in rat pontine reticular formation. J Pharmacol Exp Ther 2006;317:163-71.
32. Waite PME, Tracey DJ. Trigeminal sensory system. In: Paxinos G, eds. The rat nervous system. San Diego, CA: Academic Press; 1995:705-24.
33. Avendaño C, Machín R, Bermejo PE, Lagares A. Neuron numbers in trigeminal nuclei of the rat: A GABA- and glycine-immunocytochemical and stereological analysis. J Comp Neurol 2005;493:538-53.
34. Lewinter RD, Scherrer G, Basbaum AI. Dense transient receptor potential cation channel, vanilloid family, type 2 (TRPV2) immunoreactivity defines a subset of motoneurons in dorsal lateral nucleus of the spinal cord, the nucleus ambiguus and the trigeminal motor nucleus in rat. Neuroscience 2008;151:164-73.
35. Cropper EC, Eisenman JS, Azmitia EC. 5-HT-Immunoreactive fibers in the trigeminal nuclear complex. Exp Brain Res 1984;5:515-22.
36. Olzewski J. On the anatomical and functional organization of the spinal trigeminal nucleus. J Comp Neurol 1950;92:401-13.
37. Jelev A, Sood S, Liu H, Nolan P, Horner RL. Microdialysis perfusion of 5-HT into hypoglossal motor nucleus differentially modulates genioglossus activity across natural sleep-wake states in rats. J Physiol 2001;532:467-81.
38. Catterall WA. Cellular and molecular biology of voltage-gated sodium channels. Physiol Rev 1992;72:S15-48.
39. Baghdoyan HA, Lydic R. M2 muscarinic receptor subtype in the feline medial pontine reticular formation modulates the amount of rapid eye movement sleep. Sleep 1999;22:835-47.
40. Sugita S, Uchimura N, Jiang Z, North RA. Distinct muscarinic receptors inhibit release of gamma aminobutyric acid and excitatory amino acids in mammalian brain. Proc Nat Acad Sci 1991;88:2608-11.
41. Lee LH, Friedman DB, Lydic R. Respiratory nuclei share synaptic connectivity with pontine reticular regions regulating REM sleep. Am J Physiol 1995;268:L251-62.
42. Cairns BE, Fragoso MC, Soja PJ. Active-sleep related suppression of feline trigeminal sensory neurons: evidence implicating presynaptic inhibition via a process of primary afferent depolarization. J Neurophysiol 1996a;75:1152-62.
43. Lydic R, Baghdoyan HA. Acetylcholine modulates sleep and wakefulness: a synaptic perspective. In: Monti JM, Pandi-Perumal SR, Sinton CM, eds. The Neurochemistry of Sleep and Wakefulness. Cambridge, UK: Cambridge University Press; 2008:109-43.
44. Yaksh TL. The spinal action of opioids. In: Herz A, eds. Handbook of Experimental Pharmacology. New York, NY: Springer-Verlag; 1993:53-90.
45. Gutstein HB, Akil H. Opioid analgesics. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York, NY: McGraw-Hill; 2006:547-90.
46. Kushida K, Ishida K, Kikuta J, Kato M, Uchiyama T, Taguchi K. Alpha 2-adrenoceptor modulates the release of acetylcholine from the rostral ventrolateral medulla in response to morphine. Biol Pharm Bull 2003;26:1548-51.
47. Kalyuzhny AE, Dooyema J, Wessendorf MW. Opioid- and GABAA-receptors are co-expressed by neurons in rat brain. Neuroreport 2000;11:2625-8.
48. McDavid S, Lund JP, Auclair F, Kolta A. Morphological and immunohistochemical characterization of interneurons within the rat trigeminal motor nucleus. Neuroscience 2006;139:1049-59.
49. Aldes LD, Boone TB. Organization of projections from the principal sensory trigeminal nucleus to the hypoglossal nucleus in the rat: an experimental light and electron microscopic study with axonal tracer techniques. Exp Brain Res 1985;59:16-29.
50. Bonica JJ. The Management of Pain, Vol. I. Philadelphia, PA: Lea & Febiger; 1990.
51. Aakerlund LP, Rosenberg J. Postoperative delirium: treatment with supplementary oxygen. Br J Anaesth 1994;72:286-90.
52. Bonafide CP, Aucutt-Walter N, DiVittore N, King T, Bixler EO, Cronin AJ. Remifentanil inhibits rapid eye movement sleep but not the nocturnal melatonin surge in humans. Anesthesiology 2008;108:627-33.
53. Kay DC, Eisenstein RB, Jasinski DR. Morphine effects on human REM state, waking state, and NREM sleep. Psychopharmacologica (Berlin) 1969;14:404-16.
54. Rosenberg J. Sleep disturbances after non-cardiac surgery. Sleep Med Rev 2001;5:129-37.
55. Shaw IR, Lavigne G, Mayer P, Choinière M. Acute intravenous administration of morphine perturbs sleep architecture in healthy pain-free young adults: a preliminary study. Sleep 2005;28:677-82.
56. Walder B, Tramèr MR, Blois R. The effects of two single doses of tramadol on sleep: a randomized, cross-over trial in healthy volunteers. Eur J Anaesthesiol 2001;18:36-42.
57. Arankowsky-Sandoval G, Gold PE. Morphine-induced deficits in sleep patterns: attenuation by glucose. Neurobiol Learn Mem 1995;64:133-8.
58. Greenwald MK, Roehrs TA. Mu-opioid self-administration vs passive administration in heroin abusers produces differential EEG activation. Neuropsychopharmacology 2005;30:212-21.
59. Mayo-Michelson L, Young GA. Genetic profiles of morphine-induced EEG, EEG power spectra, and behavior in two inbred rat strains. Brain Res Bull 1993;30:79-84.
60. Menefee LA, Cohen MJA, Anderson WR, Doghramji K, Frank ED, Lee H. Sleep disturbance and nonmalignant chronic pain: a comprehensive review of the literature. Pain Med 2000;1:156-72.
61. Osman NI, Baghdoyan HA, Lydic R. Morphine inhibits acetylcholine release in rat prefrontal cortex when delivered systemically or by microdialysis to basal forebrain. Anesthesiology 2005;103:779-87.
62. Haack M, Mullington JM. Sustained sleep restriction reduces emotional and physical well-being. Pain 2005;119:56-64.
63. Onen SH, Alloui D, Jourdan D, Eschalier A, Dubray C. Effects of rapid eye movement (REM) sleep deprivation on pain sensitivity in the rat. Brain Res 2001;900:261-7.
64. Chiu YH, Silman AJ, Macfarlane GJ, et al. Poor sleep and depression are independently associated with a reduced pain threshold. Results of a population based study. Pain 2005;115:316-21.
65. Roehrs T, Hyde M, Blaisdell B, Greenwald M, Roth T. Sleep loss and REM sleep loss.are hyperalgesic. Sleep 2006;29:145-51.
66. Baghdoyan HA. Hyperalgesia induced by REM sleep loss: a phenomenon in search of a mechanism. Sleep 2006;29:137-9.
67. Smith MT, Edwards RR, McCann UD, Haythornthwaite JA. The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep 2007;30:494-505.
68. Phillips DM. JCAHO pain management standards are unveiled. JAMA 2000;284:428-9.
69. Avidan MS, Zhang L, Burnside BA, et al. Anesthesia awareness and the bispectral index. N Engl J Med 2008;358:1097-108.
70. Katayama Y, Tsubokawa T, Hirayama T, Yamamoto T. Pain relief following stimulation of the pontomesencephalic parabrachial region in humans: brain sites for nonopiate-mediated pain control. Appl Neurophysiol 1985;48:195-200.
71. Hood DD, Eisenach JC, Tuttle R. Phase I safety assessment of intrathecal neostigmine methylsulfate in humans. Anesthesiology 1995;82:331-43.
72. Hood DD, Mallak KA, James RL, Tuttle R, Eisenach JC. Enhancement of analgesia from systemic opioid in humans by spinal cholinesterase inhibition. J Pharmacol Exp Ther 1997;282:86-92.
73. Eisenach JC. Muscarinic-mediated analgesia. Life Sci 1999;64:549-54.
74. Flood P, Daniel D. Intranasal nicotine for postoperative pain treatment. Anesthesiology 2004;101:1417-21.
75. Harvig P, Gillberg PG, Gordh T, Post C. Cholinergic mechanisms in pain and analgesia. Trends Pharmacol Sci 1989;10(Suppl):75-9.
76. Klamt JG, Prado WA. Antinociception and behavioral changes induced by carbachol microinjected into identified sites of the rat brain. Brain Res 1991;549:9-18.
77. Kshatri AM, Baghdoyan HA, Lydic R. Cholinomimetics, but not morphine, increase antinociceptive behavior from pontine reticular regions regulating rapid eye movement sleep. Sleep 1998;21:677-85.
78. Ma H-C, Dohi S, Wang Y-F, Ishizawa Y, Yanagidate F. The antinociceptive and sedative effects of carbachol and oxycodone administered into brainstem pontine reticular formation and spinal subarachnoid space in rats. Anesth Analg 2001;92:1307-15.
79. Ortega-Legaspi JM, Lopez-Avila A, Coffeen U, del Angel R, Pellicer F. Scopolamine into the anterior cingulate cortex diminishes nociception in a neuropathic pain model in the rat: an interruption of 'nociception-related memory acquisition'? Eur J Pain 2003;7:425-9.
80. Dussor GO, Helesic G, Hargreaves KM, Flores CM. Cholinergic modulation of nociceptive responses in vivo and neuropeptide release in vitro at the level of the primary sensory neuron. Pain 2004;107:22-32.
81. Prado WA, Segalla DK. Antinociceptive effects of bethanechol or dimethylphenylpiperazinium in models of phasic or incisional pain in rats. Brain Res 2004;1018:272-82.
82. Lynch JJ, Wade CL, Mikusa JP, Decker MW, Honore P. ABT-594 (a nicotinic acetylcholine agonist): anti-allodynia in a rat chemotherapy-induced pain model. Eur J Pharm 2005;509:43-8.
83. Wamsley JK, Lewis MS, Young WS, 3rd, Kuhar MJ. Autoradiographic localization of muscarinic cholinergic receptors in rat brainstem. J Neurosci 1981;1:176-91.
84. Baghdoyan HA, Mallios VJ, Duckrow RB, Mash DC. Localization of muscarinic receptor subtypes in brain stem areas regulating sleep. Neuroreport 1994;5:1631-4.
85. Capece ML, Baghdoyan HA, Lydic R. Carbachol stimulates [35S]guanylyl 5′-(gamma-thio)-triphosphate binding in rapid eye movement sleep-related brainstem nuclei of rat. J Neurosci 1998;18:3779-85.
86. DeMarco GJ, Baghdoyan HA, Lydic R. Differential cholinergic activation of G proteins in rat and mouse brainstem: relevance for sleep and nociception. J Comp Neurol 2003;457:175-84.